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Abstract
Background Multidetector computed tomography (MDCT)
has become the main investigation of choice for staging of
many cancers.
Aim The purpose of this pictorial review is to discuss the
imaging appearances on CT of some of the more common
cancers arising within the abdomen and pelvis and to
describe their typical sites of local, nodal and haematoge-
nous tumour spread.
Methods Cancers arising from the stomach, pancreas,
colon, kidney, ovary and prostate will be reviewed.
Results Awareness of the characteristic sites of tumour
spread is important to allow accurate identification of all
sites of disease.
Conclusion This will clearly have an impact on both patient
management and prognosis.
Keywords Multidetector CT.Abdomen.Pelvis.
Neoplasm.Metastases
Introduction
In the last 2 decades, cross-sectional imaging, in particular
multidetector computed tomography (MDCT), has become
the main investigation of choice in the locoregional and
distant staging of many tumours within the abdomen and
pelvis. MDCT benefits from having a high spatial resolu-
tion and fast acquisition time, making it an ideal tool to
stage and restage tumours. The routine use of intravenous
(and oral contrast) media, unless contraindicated, also helps
to delineate sites of disease, especially within solid organs.
The identification of nodal involvement on CT is based on
nodal size, typically using a minimum cutoff of 1 cm in
short axis diameter, although this can lead to both under-
and over-staging of metastatic nodal involvement. The
purpose of this pictorial review is to discuss the imaging
appearances on CT of some of the more common cancers
arising within the abdomen and pelvis and to describe their
typical sites of local, nodal and haematogenous tumour
spread. Cancers arising from the stomach, pancreas, colon,
kidney, ovary and prostate will be reviewed, with summary
tables provided. Lymphoma will not be specifically
discussed.
Gastric cancer
Ninety percent of tumours are adenocarcinomas, which are
subdivided into two main histological types: (1) the well-
differentiated (intestinal) type, which is associated with
atrophic gastritis, occurs in older patients and has a better
survival rate and (2) the undifferentiated (diffuse/signet
ring) type, which is more common, occurs more frequently
in women and has a poorer prognosis [1]. Gastric
adenocarcinoma occurs either proximally (cardia) or distal-
ly (non-cardia), with the former increasing in incidence
whilst the latter is declining (see Table 1).
On CT, the use of oral contrast agents to distend the
stomach is essential, preferably with water rather than dilute
gastrograffin to avoid beam-hardening artefacts. Involvement
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inner/middle layer of the gastric wall (T1 tumours) or
transmural thickening with abnormal contrast enhancement
(T2 tumours) [2]. Wall thickness has been reported to be
greater and of higher attenuation in the diffuse histological
type compared to the intestinal type [3]. Gastric cancer
spreads in a predictable fashion through the gastric wall with
the presence of perigastric fat stranding and nodular outline
suggestive of serosal involvement (T3 tumours) (Fig. 1).
Direct invasion into adjacent organs and structures indicates
T4 tumours.
Spread to perigastric and less frequently other intra-
abdominal nodes may occur (Table 1; Fig. 1). Troisier’s
sign describes the clinical finding of an enlarged left
supraclavicular lymph node due to metastatic involvement.
Abdominal cancers may metastasise to this site via the
thoracic duct, and gastric malignancy is classically
described as the commonest primary tumour to do this.
Obstructive jaundice with associated bile duct dilatation
may occur, due to enlarged porta hepatis nodes or due to
the spread of gastric tumour via the gastrohepatic ligament
directly into the liver.
Haematogeneous spread via the portal vein to the liver
occurs in 25% of patients at presentation, with liver
metastases typically appearing as rim-enhancing low-
attenuation lesions during the portal venous phase. Peritoneal
spread occurs in a similar percentage at presentation.
Peritoneal disease secondary to gastric adenocarcinoma may
mimic the appearance of peritoneal disease secondary to
metastatic ovarian carcinoma, with omental cake and/or
discreteperitonealdepositsnotedwithintheabdominalcavity.
Trans-coelomic spread is also characteristic of gastric cancer,
withspreadtotheovaryresultinginaKrukenbergtumourthat
typically appears as a mixed solid/cystic adnexal mass.
Involvement of the peritoneal reflection within the pelvis
can result in a positive Blumer’s shelf finding, with tumour
found high on the anterior rectal wall [4].
It should be noted that other histological tumour types
arising from the stomach have different patterns of tumour
spread. Gastrointestinal stromal tumours (GISTs) are the most
common primary mesenchymal neoplasms of the gastrointes-
tinal tract, distinct from true smooth muscle and neural
tumours, and are derived from the interstitial cells of Cajal.
They are most frequently located within the stomach (60–
70%) and should be regarded as having malignant potential.
GISTs typically involve the outer muscular layer of the GI
tract, and thus often demonstrate exophytic growth (Fig. 2).
Most appear as well-defined extraluminal or combined
intraluminal/extraluminal masses on CT. If small, they tend
to be of homogeneous attenuation; if larger, they are more
heterogeneous on both the unenhanced and enhanced scans
because of necrosis or haemorrhage [5]. The central areas of
necrosis may communicate with the gastric lumen. Displace-
ment of adjacent structures is more often seen than direct
invasion. If arising from the stomach, the tumour may extend
into the gastrohepatic ligament, the gastrosplenic ligament
and the lesser sac. Nodal spread is extremely rare, but
haematogenous spread can occur, often to the liver with
nearly 50% of patients with GISTs presenting with metas-
tases (Fig. 2)[ 5]. Peritoneal seeding is also seen. Less
commonly, metastases to the soft tissue, lungs and pleura
may occur. Metastatic deposits have similar CT character-
istics to the primary GIST [6].
Pancreatic cancer
Pancreatic ductal adenocarcinoma accounts for more than
80% of malignant tumours of the pancreas, and 70% of
Fig. 1 Gastric adenocarcinoma: axial contrast-enhanced CT (CECT)
showing tumour arising from the lesser curvature of the stomach
(asterisk) associated with enlarged regional gastrohepatic nodes
(arrows)
Table 1 Summary table of local, nodal and haematogenous spread in
gastric cancer
Local spread ￿Local spread into adjacent structures (e.g.
pancreas, colon, spleen)
Lymph node
spread
￿Perigastric: pericardial; lesser curvature; greater
curvature; suprapyloric
￿Extraperigastric: left gastric; common hepatic;
coeliac; splenic hilum and artery; hepatic
pedicle; retropancreatic; mesenteric root; middle
colic; para-aortic
Haematogenous
spread
￿Most commonly the liver (25% at presentation)
and peritoneum
Notes ￿Transcoelomic spread can occur through the
peritoneum (e.g. Kruckenberg tumours)
￿Retropancreatic, para-aortic and mesenteric
nodes are classified as M1 metastatic disease
￿Nodal disease in GIST tumours is extremely rare
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imaging modality used for staging of suspected pancreatic
cancer with CT (along with MRI and endoscopic sonogra-
phy) used to distinguish between potentially resectable and
non-resectable patients. For cancer at the head of the
pancreas, curative surgery involves a pancreaticoduodenec-
tomy (Whipple procedure). Contraindications to surgery
include distant metastases, circumferential involvement of
the superior mesenteric vein-portal vein segment more than
2 cm long, thrombus in the vein, and occlusion or
circumferential invasion of the celiac, hepatic or superior
mesenteric arteries [7] (see Table 2).
Fig. 2 Gastrointestinal stromal tumour (GIST): axial CECT showing
typical large low attenuation exophytic tumour (asterisk) arising from
the greater curvature of the stomach associated with liver metastasis
(arrow). Note there are no significantly enlarged regional nodes
Table 2 Summary table of local, nodal and haematogenous spread in
pancreatic cancer
Local spread ￿Tumour spreads by direct perivascular and
perineural invasion;
￿Local invasion can involve the stomach,
duodenum and retroperitoneum;
￿Head/uncinate process tumours: these usually
extend along the SMA and mesenteric root;
￿Body/tail tumours: these usually infiltrate the
celiac, hepatic or splenic arteries
Lymph node
spread
￿Primary drainage: superior, inferior, anterior,
posterior and splenic lymph nodes;
￿Secondary drainage: porta hepatis, common
hepatic, coeliac, mesenteric root lymph nodes;
￿Tertiary drainage: peri-aortic and distal superior
mesenteric lymph nodes
Haematogenous
spread
￿These usually involve the liver and peritoneal
surfaces
Note ￿Early lymphatic and haematogenous
micrometastases at presentation are common
Fig. 3 Pancreatic adenocarcinoma: a axial CECT showing an
example of a tumour arising in the head of the pancreas (asterisk)
with invasion into the duodenum. There is a focal thrombus in the
portal vein (arrow); b axial CECT in same patient as (a); there is
associated intra- (arrows) and extrahepatic (not shown) bile duct
dilatation; c axial CECT showing a large bulky tumour in a different
patient arising in the body of the pancreas (asterisk) encasing the
origin of the celiac axis
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contrast-enhanced acquisitions (during the late arterial and
venous phases) are advised. Again oral contrast with water
is helpful to allow delineation of the duodenal wall.
The pancreas is a retroperitoneal organ and has a close
anatomic relationship with the abdominal peritoneal reflec-
tions. The pancreatic head is connected to the liver and lesser
curvature ofthe stomachvia the hepatoduodenalligamentand
gastrohepatic ligaments, respectively. The tail of the pancreas
is in continuity with the hilum of the spleen and the greater
curvatureofthestomachviathesplenorenalandgastrosplenic
ligaments. Pancreatic cancer can invade these adjacent
peritoneal ligaments (as well as the transverse mesocolon) to
involve the stomach, duodenum (Fig. 3a) and retroperito-
neum [8]. Tumour tends to spread by direct perivascular and
perineural invasion within the subperitoneal space [8]. If
arising from the pancreatic head or uncinate process,
tumours usually extend along the superior mesenteric artery
and root of the mesentery. Biliary and pancreatic duct
dilatation may develop (Fig. 3b). Tumours in the body
(Fig. 3c) and tail spread to encase the celiac, hepatic and
splenic arteries. Encasement of the proximal superior
mesenteric and portal veins can also be seen.
Table 3 Summary table of local, nodal and haematogenous spread in
colorectal cancer
Local spread ￿Invasion through the bowel wall into the peri-
colonic fat and adjacent structures
Lymph node
spread
￿Follows the vascular distribution of vessels in
mesocolon;
￿Ascending mesocolon: nodes along the ileocolic
vessels and right colic vessel;
￿Transverse mesocolon: nodes along the middle
colic vessels;
￿Sigmoid and descending mesocolon: nodes along
the inferior mesenteric vein;
￿Regional lymph nodes for rectal cancers include:
mesorectal, sigmoid mesenteric, inferior
mesenteric, lateral sacral, presacral, internal
iliac, sacral promontory, superior rectal, middle
rectal and inferior rectal
Haematogenous
spread
￿Liver (via the portal vein)>lung, adrenal glands,
bones
Notes ￿In rectal cancers that have perforated the
peritoneum, transcoelomic spread favours the
lower right small bowel mesentery and the
pouch of Douglas
Fig. 4 Colonic adenocarcinoma: a axial non-contrast-enhanced CT
showing tumour (asterisk) in the ascending colon with enlarged
ileocolic nodes (arrows); b axial contrast-enhanced CT shows a large
liver metastasis (asterisk)
Fig. 5 Rectal adenocarcinoma: coronal reformat CECT showing a
bulky rectal tumour (asterisk) with enlarged right internal iliac nodes
(double asterisk) and left paraaortic node (arrow)
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peripancreatic nodes, nodes at the celiac axis and porta
hepatis, or sometimes nodes further afield (Table 2).
Haematogeneous spread also arises, with involvement of
the liver and peritoneal surfaces. Distant metastases are
found in more advanced cases.
Colorectal cancer
Most colorectal cancers arise from adenomatous polyps, with
p o l y p sg r e a t e rt h a n2c mi ns i z ea s s o c i a t e dw i t hag r e a t e rt h a n
40% risk of malignancy. For local staging of rectal cancer, MRI
is now the standard imaging modality because of its increased
soft tissue resolution and multiplanar capabilities. Colorectal
tumours may appear as polypoid or infiltrative lesions of the
b o w e lw a l l( F i g .4a), leading to luminal narrowing and an
apple core appearance [9]. Early colonic tumours are better
detected when endoluminal distension is given and the colon
has been prepared, as in CT colonography. Tumour spread
through the serosa appears as pericolonic fat stranding, but
may be confused with an associated desmoplastic reaction
(possibly mimicking diverticulitis within the sigmoid colon).
The presence of fluid in the root of the sigmoid mesentery and
Fig. 6 Pseudomyxoma peritoneii: axial CECT showing mucinous
ascites exerting mass effect (scalloping) on the solid organs; primary
was of gastrointestinal tract origin
Fig. 7 Metastatic renal cell carcinoma: a coronal reformat CECT
showing the inferior vena cava (IVC) greatly expanded by tumour
thrombus (arrows) with associated enlarged mediastinal nodes
(asterisks). The primary renal tumour has been excised; b axial CECT
showing enhancing lesion in the left gluteus maximus muscle in the
same patient, which increased in size on interval CT studies, in
keeping with a metastatic deposit; note the numerous venous
collaterals in the anterior abdomen (short arrows) due to the IVC
thrombus; c axial CECT shows a large lytic deposit in the lumbar
spine (asterisk) in the same patient causing compromise of the spinal
canal and cord (arrows)

Insights Imaging (2011) 2:205–214 209engorgement of the adjacent sigmoid mesenteric vasculature
favours diverticulitis, whilst the presence of pericolic lymph
nodes is suspicious for colon cancer [10]. Tumour spread to
adjacent organs is suggested by loss of the fat planes and
direct invasion (see Table 3).
Nodal spread depends on the site of the primary tumour
and follows the vascular distribution of the vessels within
the mesocolon [11, 12]. These vessels include the ileocolic
vessels and right colic vessel for the ascending mesocolon,
the middle colic vessels for the transverse mesocolon, and
the inferior mesenteric vein for the sigmoid and descending
mesocolon. For rectal tumours, drainage is usually cranial
within the mesorectum to involve the regional lymph nodes
(Table 3). Involvement of pelvic side wall nodes (Fig. 5)i s
less common, with involvement of the inguinal nodes only
seen with lower rectal tumours when there is proximal
lymphatic blockage (e.g. extensive adenopathy).
Metastaticdisease at presentation is uncommon (<10–15%
of cases). Haematogeneous spread is predominantly seen
within the liver, with metastases deriving their blood supply
from the hepatic artery (compared to normal liver parenchy-
ma, which is primarily supplied by the portal vein). As a
result, liver metastases imaged during the portal venous phase
are seen as heterogeneous ring-enhancing metastases that are
hypodense to the surrounding liver parenchyma (Fig. 4b). If
the primary cancer is mucinous, liver metastases may be
cystic or calcified. Sites of distant metastases are determined
by the venous drainage of the primary site [9]. For example,
the venous drainage of the colon and upper rectum is via the
portal vein, and thus the liver is a common site of spread.
However, the lower rectum has a dual drainage, with the
superior haemorrhoidal vein draining into the inferior
mesenteric vein and then into the portal vein, and the middle
and inferior haemorrhoidal veins draining into the pelvic
veins and then directly into the inferior vena cava. This
explains why distal rectal cancers can result in isolated
pulmonary metastases without hepatic metastases.
Other common sites of metastases include the lungs,
adrenal glands and the bones. If rectal tumours perforate the
peritoneal membrane, transcoelomic spread may occur,
favouring the lower right small bowel mesentery and pouch
of Douglas. If colorectal tumours are of mucinous histol-
ogy, widespread intraperitoneal mucinous metastases may
occur with characteristic scalloping of adjacent viscera
(pseudomyxoma peritoneii) (Fig. 6).
Renal cell carcinoma (RCC)
On CT, renal tumours appear as hypervascular masses, with
larger lesions of heterogenous attenuation. With increasing
size, they spread through the renal capsule into the
perinephric fat to involve Gerota’s fascia. Early extension
through the renal capsule is recognized by an indistinct
tumour margin, thickened perirenal fascia and perinephric
fat stranding [13]. Extension into the renal vein occurs in
20% of patients at presentation with involvement of the
inferior vena cava (IVC) in 5–10% of patients (Fig. 7a)
[13]. This is more likely with larger tumours. Tumour
thrombus is seen as a filling defect within the vein, which
should not be confused with streaming artefact from
unopacified blood. The presence of venous distension on
its own may be misleading as RCCs are hypervascular and
hence tend to have increased blood flow and venous
drainage. Distinction between tumour thrombus and bland
thrombus within the IVC may be difficult, although the
former may have enhancing tumour vessels within it. In
advanced tumours, direct invasion into adjacent structures
such as the diaphragm, and posterior abdominal wall
muscles may be seen (see Table 4).
Lymphatic spread from RCC tends to follow the renal
veins to involve the ipsilateral para-aortic nodes. There are
Table 4 Summary table of local, nodal and haematogenous spread in
renal cell carcinoma
Local spread ￿Perinephric fat; ipsilateral adrenal; adjacent
viscera (including muscles);
￿Renal vein invasion (± IVC)
Lymph node
spread
￿Via lymphatics following the renal vessels to the
ipsilateral para-aortic nodes; direct connections
with the thoracic duct and mediastinum also
exist
Haematogenous
spread
￿Common sites: lungs>bones, CNS, adrenals
Note ￿Extension into renal vein occurs in 20% of
patients at presentation; IVC involvement in
5–10%
Table 5 Summary table of local, nodal and haematogenous spread in
ovarian carcinoma
Local spread ￿Uterus and broad ligament (via the fallopian
tube);
￿Direct invasion of the rectum, colon, bladder and
pelvic side wall
Lymph node
spread
￿Via lymphatics travelling along with the ovarian
vessels to terminate in common iliac and para-
aortic nodes;
￿Via the broad ligament to terminate in the
internal iliac and obturator nodes;
￿Via the round ligament to terminate in the
external iliac and inguinal nodes
Trans-coelomic
spread
￿Common sites: undersurface of the diaphragm,
liver surface, pouch of Douglas, omentum,
serosal bowel surfaces
Haematogenous
spread
￿This occurs late during the disease;
￿Liver>lungs, kidney, bone
Note ￿Ascites arise from increased production from
tumour surfaces and/or occlusion of
retroperitoneal lymph nodes
210 Insights Imaging (2011) 2:205–214Fig. 8 Ovarian carcinoma: coronal reformat CECT showing a large
solid/cystic adnexal mass arising from the pelvis (asterisk), with large-
volume para-aortic adenopathy (double asterisk), ascites and small
peritoneal deposits (arrows). Although para-aortic nodal involvement
is seen in metastatic ovarian carcinoma, the large volume is rather
unusual; b sagittal reformat CECT showing subcapsular deposits
over the liver in a different patient (arrows); c axial CECT in the
same patient as (b) showing a thick omental cake (arrows); d axial
CECT in the same patient as (b) showing multiple enlarged (short
axis diameter >5 mm) cardiophrenic nodes (arrows)
Table 6 Summary table of local, nodal and haematogenous spread in prostate cancer
Local spread ￿Direct extension through the prostate capsule into the seminal vesicles and bladder base
Lymph node spread ￿Order of nodal involvement: obturator, presacral, internal iliac, common iliac
Haematogenous
spread
￿Bone >> lung and liver;
￿Spinal bone metastases are the commonest site (due to the direct communication between the presacral and periprostatic veins)
Notes ￿Denonvillier’s fascia forms a relative natural barrier to rectal spread;
￿Tumours at the apex of the prostate are more likely to demonstrate extracapsular extension because of relatively little capsule
at this level
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tinum, which can account for the rare presence of
mediastinal and hilar node involvement (Fig. 7a)a t
presentation (especially on the right side).
Between 25–35% of patients with RCC have metastases
at diagnosis [14]. Metastatic involvement in renal cell
carcinoma is seen (in order of decreasing frequency) in: the
lung (50–60%), bone (30–40%), liver (30–40%), adrenal
gland (5%), contralateral kidney (5%), retoperitoneum (5%)
and brain (5%) [14]. More unusual sites that have been
reported include the pancreas, peritoneum, bowel, thyroid
and muscle (Fig. 7b) and subcutaneous tissues. Visceral
metastases tend to be hypervascular, similar to the primary
tumour. Bony involvement appears as expansile lytic
lesions within the axial skeleton (Fig. 7c).
Ovarian carcinoma
Cross-sectional imaging (CT or MRI) is used for preoper-
ative tumour assessment, with CT being the imaging
modality of choice for assessing metastatic disease. Bowel
opacification is usually achieved with a positive oral
contrast medium (e.g. dilute gastrograffin), which is
essential for the detection of peritoneal deposits. Intrave-
nous contrast is also routinely administered unless contra-
indicated, with imaging performed in the portal venous
phase. Conversely, local pelvic spread is better assessed
with pelvic MRI than CT (see Table 5).
Primary ovarian cancer has variable appearances, pre-
senting either as a solid mass or mixed solid/cystic lesion
(Fig. 8a). If predominantly cystic, internal septations and/or
mural nodules are seen. Ovarian cancer spreads locally [15]
to adnexal structures, the uterus and the contralateral ovary,
although bilateral ovarian cancer may occur in 11–50% of
cases. Invasion of the pelvic side wall is indicated when the
tumour is seen encasing the iliac vessels or is within 3 mm
o ft h ep e l v i cs i d e w a l l[ 16]. Direct infiltration of the
rectosigmoid colon or bladder wall may be seen.
Peritoneal dissemination is the commonest mode of
spread, being found in approximately 70% of patients at
presentation. Common sites include the greater omentum,
paracolic gutters, the pouch of Douglas, the liver capsule
(Fig. 8b), the diaphragm and bowel serosa. Less commonly,
implants may be seen within the mesentery, along the porta
hepatis, lesser sac, splenic surface and gastrosplenic
ligament [16–18]. Ascites are often present, due to either
increased production from tumour surfaces or reduced
peritoneal resorption from invasion of lymphatics by
tumour cells. Peritoneal deposits on CT have a variety of
Fig. 9 Prostate carcinoma: a coronal reformat CECT showing
irregular enlarged prostate tumour (white arrow) extending into the
bladder with enlarged left pelvic side wall node (black arrow), liver
metastases (double arrows) and lesion in the left pubic ramus with
large soft tissue component (*). Note the bones are sclerotic in
keeping with diffuse bony metastases; b sagittal reformat CECT in a
different patient on bone windows, showing multiple sclerotic
metastases in the thoracolumbar spine
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lesions, linear/plaque-like thickening of peritoneal reflec-
tions (Fig. 8a), thick omental cakes (Fig. 8c), tiny
calcifications or mixed solid and cystic or purely cystic
lesions [19, 20]. The involvement of bowel serosa can lead
to (asymmetric) bowel wall thickening, tethering of bowel
loops and bowel obstruction. Liver surface implants
(subcapsular deposits) may be seen, with deposits causing
characteristic scalloping of the liver capsule. Metastatic
mucinous tumours of the ovary can lead to pseudomyxoma
peritoneii, although in many of these cases, the primary
mucinous tumour actually arises from the gastrointestinal
tract with secondary involvement of the ovary.
Lymphatic spread occurs via three routes and is usually
seen in conjunction with peritoneal spread. Routes include:
(1) along the ovarian vessels to the common iliac and para-
aortic nodes (Fig. 8a); (2) via the broad ligament and
parametria to the internal iliac and obturator nodes; and (3)
rarely via the round ligaments to the external iliac and
inguinal nodes. Cardiophrenic nodes (defined as >5 mm
short axis diameter on CT) [21] are characteristically
involved as they are the main lymphatic drainage route
from the peritoneal cavity (Fig. 8d).
Haematogenous dissemination is rare in ovarian carci-
noma with a malignant pleural effusion being the most
common manifestation. At presentation, liver metastases
are seen in less than 1% of cases. Other sides of spread
include the spleen, kidneys, adrenals, lungs, brain and bone.
Prostate carcinoma
MRI is traditionally used for local staging of prostate
cancer because of its high contrast resolution (as in rectal
cancer). It is able to differentiate organ-confined disease
from tumour that demonstrates extracapsular spread. Direct
involvement of the seminal vesicles or adjacent organs is
also well seen on MRI. CT is used for nodal and distant
staging of prostate cancer (see Table 6).
Classically, two lymph node metastatic patterns have
been reported [22]. Pattern 1 includes metastatic spread to
pelvic (Fig. 9a) and para-aortic lymph nodes, and this
pelvic nodal involvement is sequential with spread to the
obturator nodes, presacral nodes, internal iliac and common
iliac nodes. Pattern 2 involves para-aortic nodes only, with
this second pattern of nodal spread felt to be due to
haematogenous dissemination.
Distant spread occurs in one third of patients with
involved sites including bone (90%), lung (50%), liver
(25%) (Fig. 9a), pleura (21%) and adrenals (13%) [23].
Osteoblastic sclerotic metastases rather than lytic bone
lesions are usually seen on CT. In order of decreasing
frequency, skeletal metastases are seen within the vertebrae
(Fig. 9b), sternum, pelvic bones, ribs and femora. Spinal
involvement is initially more common within the lumbar
region and less likely within the cervical spine (97% cf.
38%), suggestive of upward metastatic spread along the
spinal veins [23]. Pulmonary metastases occur in between
5–27% of patients at presentation [24] and are more often
seen in association with the second pattern of nodal
involvement [22]. Pulmonary involvement can either
appear as lymphangitis carcinomatosa (due to direct
invasion of the pulmonary lymphatics) or as pulmonary
nodules (due to haematogenous spread) [22, 24].
Conclusion
This review has described the typical patterns of tumour
spread for the more common cancers occurring within the
abdomen and pelvis. Sites of nodal and haematogenous
dissemination clearly vary depending on tumour type.
Knowledge of the characteristic sites of spread in such
cancers is felt to be essential for the radiologist when
reporting staging and restaging CT scans. It is hoped that
the summary tables in particular will act as a useful aide-
mémoir to the reporting radiologist. Correct identification
of metastatic sites of disease is important, as this will not
only have an impact on patient management, but also a
bearing on patient prognosis.
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